© 2017

Metal Nanoparticles in Pharma

  • Mahendra Rai, Ph.D
  • Ranjita Shegokar, Ph.D


  • First book about metal nanoparticles to be completely focused on their biomedical or clinical applications

  • Comprehensive overview of metal nanoparticle processes

  • Develops several novel nanoparticle-based strategies for oncotherapy


Table of contents

  1. Front Matter
    Pages i-xviii
  2. Metal Nanoparticles in Medicine

    1. Front Matter
      Pages 1-1
    2. Irina A. Shurygina, Michael G. Shurygin
      Pages 21-37
    3. Marcela Durán, Wagner J. Fávaro, German A. Islan, Guillermo R. Castro, Nelson Durán
      Pages 39-51
    4. Anisha D’Souza, Ranjita Shegokar
      Pages 53-76
    5. Kelly J. Dussán, Ellen C. Giese, Gustavo N. A. Vieira, Lionete N. Lima, Debora D. V. Silva
      Pages 77-99
    6. Ana Rosa Ribeiro, Sara Gemini-Piperni, Sofia Afonso Alves, José Mauro Granjeiro, Luís Augusto Rocha
      Pages 101-121
    7. Krystyna I. Wolska, Anna M. Grudniak, Katarzyna Markowska
      Pages 123-138
    8. Heejeong Lee, Dong Gun Lee
      Pages 139-153
    9. Lian-Hua Fu, Jun Yang, Jie-Fang Zhu, Ming-Guo Ma
      Pages 155-191
    10. Irena Maliszewska, Katarzyna Popko
      Pages 257-278
    11. Zuzana Konvičková, Ondrej Laššák, Gabriela Kratošová, Kateřina Škrlová, Veronika Holišová
      Pages 279-294
    12. Marianna Hundáková, Kateřina Dědková, Gražyna Simha Martynková
      Pages 295-336
    13. Adriano Brandelli, Ana Carolina Ritter, Flávio Fonseca Veras
      Pages 337-363
    14. Ana S. Matias, Fábio F. Carlos, P. Pedrosa, Alexandra R. Fernandes, Pedro V. Baptista
      Pages 365-387
    15. Dilipkumar Pal, Vinod Kumar Gurjar
      Pages 389-415
  3. Toxicity Issues

    1. Front Matter
      Pages 417-417

About this book


Completely dedicated to the biomedical applications of metal nanoparticles, this book covers the different toxicity problems found in healthcare situations and also provides comprehensive info on the use of metal nanoparticles in treating various diseases. Metal Nanoparticles in Pharma is the first edited volume to set up the discussion for a clinical setting and to target a pharmaceutical audience of academic and industry-based researchers. 


biomedical application cancer therapy drug delivery nanotechonology diagnostic imaging toxicity magnetic metal oxide nanoparticles photodynamic Therapy Iton, Silver, gold, cobalt, chromiun, titanium nanoparticles photoinactivation magnetic hyperthermia collidial bio-nanoparticles biological corona wound healing bacterial quorum sensing systems Bhasma and nanometals

Editors and affiliations

  • Mahendra Rai, Ph.D
    • 1
  • Ranjita Shegokar, Ph.D
    • 2
  1. 1.Nanobiotechnology laboratory, Department of BiotechnologySGB Amravati UniversityAmravatiIndia
  2. 2.Institute of Pharmacy, Department Pharmaceutics, Biopharmaceutics & NutriCosmeticsFreie Universität BerlinBerlinGermany

About the editors

Mahendra Rai is a Professor and Head at the Department of Biotechnology, Sant Gadge Baba Amravati University at Amravati, Maharashtra, India. He was a Visiting Scientist at the Department of Bioenergetics, University of Geneva, Switzerland in 2004 and at the Department of Plant Protection of Debrecen University, Debrecen, Hungary in 2005 and 2008. He visited Department of Chemical Biology, University of Campinas, Brazil under Indo-Brazil Research Programme (DST-CNPq collaboration) in 2009, 2011 and 2012. In 2012, he was visiting Professor in Nicolaus Copernicus University, Torun, Poland. In 2013 he was invited by State University of Campinas, Brazil. He was also visiting professor in 2015 in Ostrava, Czech Republic. His area of expertise includes microbial biotechnology and nanobiotechnology. His present research interest include application of nanobiotechnology in medicine with particular reference to development of nanoantimicrobials. He has published more than 325 research papers in national and international journals. In addition, he has edited/authored more than 40 books and 6 patents.

Dr. Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India and has been postdoctoral researcher at Free University of Berlin, Department of Pharmaceutical Technology, Biopharmaceutics and NutriCosmetics, Berlin, Germany. Since last 6 years she is working for pharmaceutical industry in various technical / R & D roles. Currently, she serves as Head of Formulation Development department at Symrise AG, Germany. Dr. Shegokar has authored more than 45 research articles, 20 book chapters and 150 research abstracts. She has filed two patent applications on nanoparticles for targeting malaria and HIV/AIDS reservoirs. She is a recipient of several national and international awards for her research. Her areas of interest are oral solid dosage forms, dermal formulations, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions and galenic formulations.

Bibliographic information

Industry Sectors
Health & Hospitals
Consumer Packaged Goods